C12N 2760/18833
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/18833 (Use of viral protein as therapeutic agent other than vaccine) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 6
- Assignees
- 6
- Inventors
- 9
- Latest grant
- 4 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Gene and cell therapy using cell fusion technology4 Jun 2024US 11,998,617 B2Curamys Inc.
- Gene and cell therapy using cell fusion technology26 Dec 2023US 11,850,288 B2Curamys Inc.
- Gene and cell therapy using cell fusion technology3 Aug 2021US 11,077,207 B2Curamys Inc.
- Anti-cancer agent comprising HVJ-E and CXCL215 Oct 2019US 10,441,613 B2Genomidea Inc.
- Therapeutic/prophylactic agent for prostate cancer8 Apr 2014US 8,691,212 B2Genomldea Inc.
- Gene and cell therapy using cell fusion technology21 Oct 2021US 2021/0322570 A1Curamys Inc.
- Gene and cell therapy using cell fusion technology15 Oct 2020US 2020/0323997 A1Curamys Inc.
- Novel therapeutic agent for prionoid diseases28 Nov 2019US 2019/0358276 A1Foundation for Biomedical Research and Innovation At Kobe
- Anti-cancer agent comprising hvj-e and cxcl230 Aug 2018US 2018/0243355 A1Genomldea Inc.
- Gene and cell therapy using cell fusion technology12 Jul 2018US 2018/0193487 A1Seoul National University Hospital
Most cited
By later US patents